LDL and apoB
Reduced CETP activity accompanies an atherogenic small dense LDL profile in long-standing type 1 diabetes (Front Endocrinol 2026)
Original title: Altered small dense LDL profiles in long-standing controlled type 1 diabetes
Because type 1 diabetes confers increased cardiovascular risk despite adequate glycemic control, researchers compared small dense LDL cholesterol and its regulators in 69 individuals with long-standing type 1 diabetes and 24 healthy controls. Despite adequate glycemic control (mean HbA1c 7.6%) and near-normal lipid levels, people with type 1 diabetes had significantly higher small dense LDL cholesterol (0.56 versus 0.43 mmol/L), a higher small dense LDL to LDL cholesterol ratio, and smaller LDL particle size than controls. Apolipoprotein C3 and hepatic lipase mass and activity were significantly increased, while CETP activity was significantly reduced (808.8 versus 929.7 pmol per mL per hour), and small dense LDL cholesterol correlated positively with apolipoprotein C3 (r equals 0.7517) and inversely with CETP activity (r equals -0.2682), implicating reduced CETP activity alongside apoC3 and hepatic lipase in the atherogenic small dense LDL enrichment seen in type 1 diabetes.
Original abstract
Introduction: Small dense low-density lipoprotein (sdLDL) is a highly atherogenic LDL subclass associated with cardiovascular disease (CVD). While type 1 diabetes confers increased cardiovascular risk despite adequate glycemic control, the role of sdLDL and its regulators remains unclear.
Methods: In this cross-sectional observational study, plasma from 69 individuals with long-standing type 1 diabetes and 24 healthy controls was analyzed. sdLDL-cholesterol (sdLDL-C) concentration, sdLDL-C/LDL-cholesterol ratio, LDL size and subclasses were assessed using homogeneous assays, NMR spectroscopy, and gradient gel electrophoresis. Apolipoprotein C3 (ApoC3), hepatic lipase (HL), endothelial lipase (EL), and cholesteryl ester transfer protein (CETP) activity were measured by immunoturbidimetric, ELISA and functional assays.
Results: Despite adequate glycemic control (mean HbA1c 7.6% [60 mmol/mol]) and near-normal lipid levels, individuals with type 1 diabetes had significantly higher sdLDL-C (0.56 ± 0.28 mmol/L vs 0.43 ± 0.26 mmol/L), increased sdLDL-C/LDL-cholesterol ratio (0.20 ± 0.08 vs 0.12 ± 0.06) and smaller LDL particle size (26.32 ± 1.08 nm vs 26.81 ± 0.68 nm) compared with controls. ApoC3 and HL mass/activity were significantly increased (8.67 ± 3.22 mg/dL vs 6.53 ± 2.42; 46.60 ± 16.12 ng/mL vs 15.45 ± 7.40 ng/mL and 1.03 ± 0.24 U/mL vs 0.89 ± 0.23 U/mL; respectively), CETP activity significantly reduced (808.8 ± 197.0 pmol/mL/h vs 929.7 ± 149.6 pmol/mL/h), and endothelial lipase levels unchanged. sdLDL-C positively correlated with ApoC3 (r = 0.7517) and inversely with CETP activity (r = -0.2682).
Conclusion: Long-standing type 1 diabetes with adequate glycemic control is associated with an atherogenic sdLDL profile despite near-normal conventional lipid levels. This first multi-method characterization study of sdLDL in type 1 diabetes highlights the contribution of ApoC3, CETP and HL to sdLDL-C enrichment and suggests that direct assessment of sdLDL may improve cardiovascular risk stratification.
diabetesLDL and apoBmechanisms
Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.